Perceptions of prostate cancer patients undergoing definitive radiotherapy on the impact of prostate cancer and radiation therapy on male sexuality

被引:0
|
作者
Daniels, Joseph [1 ]
Baffoe-Krapim, Leroy [1 ,2 ]
Nyantakyi, Andrew Yaw [1 ]
Ayabilah, Edwina Ayaaba [1 ]
Tackie, Judith Naa Odey [1 ]
Kyei, Kofi Adesi [1 ,2 ]
机构
[1] Korle Bu Teaching Hosp, Natl Radiotherapy Oncol & Nucl Med Ctr, Accra, Ghana
[2] Univ Ghana, Dept Radiog, Accra, Ghana
来源
ECANCERMEDICALSCIENCE | 2024年 / 18卷
关键词
radiotherapy; prostate cancer; erectile dysfunction; premature ejaculation; sexual function; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; MEN; SYMPTOMS; RISK;
D O I
10.3332/ecancer.2024.1726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Male sexual function is an important aspect of the life of prostate cancer patients and plays a significant role in the long-term quality of life of prostate cancer survivors. However, there is a paucity of published literature on the perceived impact of prostate cancer and its treatment on the sexual function of patients in Ghana and West Africa in general. The purpose of this study was to explore the perceptions of prostate cancer patients on the effects of the disease and radiation therapy on male sexual function. The study also examined the changes in sexuality experienced by men with prostate cancer. Methods: This research was a descriptive longitudinal study conducted at the third largest hospital in Africa. The study included Ghanaian prostate cancer patients of all ages who were treated with definitive radiotherapy at the study site between October 2021 and May 2022. Quantitative data were collected and analysed using the Statistical Package for Social Sciences version 26.0 and Microsoft Excel 2019. Descriptive statistics were used to determine frequencies and percentages of the demographic characteristics. Results: The mean age of the participants was 65.7 years (SD 6.7) ranging from 50 to 81 years. Patients had different ideas about the potential adverse effects of prostate cancer (86%) and radiotherapy (70%) on male sexual function. A decrease in sexual desire (54%) was the commonest perceived effect of prostate cancer on male sexual function followed by premature ejaculation (49%) and a decrease in sexual activity (48%). On the other hand, erectile dysfunction (49%) was the commonest perceived effect of radiotherapy for prostate cancer on male sexual function followed by a decrease in sexual desire (38%) and premature ejaculation (37%). Health professionals were the major source of information regarding the perceptions of the patients on the effects of both prostate cancer (46%) and radiation therapy (43%) on male sexual function. Conclusion: There should be enhancement of awareness measures to educate Ghanaian cancer patients on the side effects and implications of treatment on their sexuality. Comprehensive sexual health assessment should be incorporated in the routine care of patients with cancers that have the potential to impact the sexual function of patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Impact of Androgen Deprivation Therapy on Sexual and Hormonal Function in Patients Receiving Radiation Therapy for Prostate Cancer
    Kushnir, Tamara
    Gofrit, Ofer N.
    Elkayam, Ruth
    Paluch-Shimon, Shani
    Lawrence, Yaacov R.
    Weiss, Ilana
    Symon, Zvi
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (01): : 49 - 53
  • [2] Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer
    Mendenhall, William M.
    Henderson, Randal H.
    Hoppe, Bradford S.
    Nichols, Romaine Charles
    Mendenhall, Nancy P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 530 - 534
  • [3] Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy
    Yildirim, Halil Cumhur
    Ergen, Sefika Arzu
    Sedef, Emine
    Sahin, Merve
    Karacam, Songul Cavdar
    Senocak, Mustafa Sukru
    Dincbas, Fazilet Oner
    INDIAN JOURNAL OF CANCER, 2020, 57 (01) : 70 - 75
  • [4] Sexuality and prostate cancer
    Colson, M. -H.
    Lechevallier, E.
    Rambeaud, J. -J.
    Alimi, J. -C.
    Faix, A.
    Gravis, G.
    Hannoun-Levi, J. -M.
    Quintens, H.
    Rebillard, X.
    Droupy, S.
    PROGRES EN UROLOGIE, 2012, 22 : S72 - S92
  • [5] Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy
    Sherer, Michael, V
    Deka, Rishi
    Salans, Mia A.
    Nelson, Tyler J.
    Sheridan, Paige
    Rose, Brent S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) : 276 - 281
  • [6] Erectile dysfunction and radiation therapy for prostate cancer
    Incrocci, L.
    SEXOLOGIES, 2006, 15 (02) : 116 - 120
  • [7] Definitive Radiotherapy for Prostate Cancer
    Mendenhall, William M.
    Henderson, Randal H.
    Mendenhall, Nancy P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (05): : 496 - 503
  • [8] Trajectories of Fatigue in Family Caregivers of Patients Undergoing Radiation Therapy for Prostate Cancer
    Fletcher, Barbara A. Swore
    Schumacher, Karen L.
    Dodd, Marylin
    Paul, Steven M.
    Cooper, Bruce A.
    Lee, Kathryn
    West, Claudia
    Aouizerat, Bradley E.
    Swift, Patrick S.
    Wara, William
    Miaskowski, Christine
    RESEARCH IN NURSING & HEALTH, 2009, 32 (02) : 125 - 139
  • [9] Endocrine therapy for recurrence after definitive radiotherapy in patients with prostate cancer
    Furuya, Y
    Akakura, K
    Tanaka, M
    Ichikawa, T
    Igarashi, T
    Murakami, S
    Ito, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (05) : 222 - 226
  • [10] Incidence of Bladder Cancer in Patients Undergoing Radiotherapy for Prostate Cancer
    Castellano, Cristina de la Encarnacion
    Nebot, Angela Canos
    Andreu, Pablo Vargas
    Carbajosa, Nuria Garcia
    Chaparro, Luis Prieto
    Sempere, Silvia Chillon
    Llopis, Juan Antonio Galan
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (07): : 655 - 662